Assenagon Asset Management
THC icon

Assenagon Asset Management’s Tenet Healthcare THC Stock Holding History

Assenagon Asset Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.08M Sell
48,533
-74,968
-61% -$13.8M 0.01% 550
2026
Q1 		$23.3M Buy
123,501
+60,693
+97% +$12.8M 0.04% 315
2025
Q4 		$12.5M Sell
62,808
-300,946
-83% -$60.8M 0.02% 463
2025
Q3 		$73.9M Buy
363,754
+279,377
+331% +$49.6M 0.1% 168
2025
Q2 		$14.9M Sell
84,377
-12,511
-13% -$1.88M 0.02% 400
2025
Q1 		$13M Sell
96,888
-157,043
-62% -$20.7M 0.02% 384
2024
Q4 		$32.1M Buy
253,931
+96,106
+61% +$14.3M 0.05% 278
2024
Q3 		$26.2M Sell
157,825
-161,970
-51% -$24.5M 0.05% 279
2024
Q2 		$42.5M Hold
319,795
– – 0.09% 158
2024
Q1 		$33.6M Buy
319,795
+72,146
+29% +$6.48M 0.08% 196
2023
Q4 		$18.7M Buy
247,649
+58,390
+31% +$3.7M 0.05% 301
2023
Q3 		$12.5M Buy
189,259
+186,649
+7,151% +$14M 0.04% 340
2023
Q2 		$212K Sell
2,610
-9,376
-78% -$667K ﹤0.01% 1276
2023
Q1 		$712K Sell
11,986
-1,943,748
-99% -$108M ﹤0.01% 1141
2022
Q4 		$95.4M Buy
1,955,734
+268,395
+16% +$12.4M 0.34% 61
2022
Q3 		$87M Buy
1,687,339
+1,063,338
+170% +$63.1M 0.33% 64
2022
Q2 		$32.8M Buy
624,001
+497,044
+392% +$34.6M 0.12% 164
2022
Q1 		$10.9M Sell
126,957
-212,305
-63% -$17.4M 0.03% 350
2021
Q4 		$27.7M Buy
339,262
+116,542
+52% +$8.52M 0.08% 174
2021
Q3 		$14.8M Sell
222,720
-439,986
-66% -$31.2M 0.05% 242
2021
Q2 		$44.4M Buy
+662,706
New +$41.1M 0.15% 123
2020
Q4 		– Sell
-24,791
Closed -$608K – 1255
2020
Q3 		$608K Sell
24,791
-127,318
-84% -$3.25M ﹤0.01% 943
2020
Q2 		$2.75M Buy
152,109
+84,733
+126% +$1.67M 0.02% 495
2020
Q1 		$970K Buy
67,376
+57,719
+598% +$1.66M 0.01% 538
2019
Q4 		$367K Buy
+9,657
New +$289K ﹤0.01% 690

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Assenagon Asset Management's THC Position: Q2 2026 in Review

Assenagon Asset Management reduced its Tenet Healthcare (THC) stake by 61% in Q2 2026, selling an estimated $13.8M and leaving 48,533 shares worth $9.08M. The position accounts for 0.01% of the portfolio, ranked #550.

Assenagon Asset Management first reported a position in THC in Q4 2019 and has held it in 25 quarters since. The position peaked at $95.4M in Q4 2022. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Assenagon Asset Management held 48,533 shares of Tenet Healthcare worth $9.08M as of Q2 2026.
  • Assenagon Asset Management sold 74,968 Tenet Healthcare shares in Q2 2026, an estimated $13.8M.
  • Tenet Healthcare made up 0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #550 holding.
  • Assenagon Asset Management first reported a position in Tenet Healthcare in Q4 2019 and has held it in 25 quarters since.
  • Assenagon Asset Management's Tenet Healthcare position peaked at $95.4M in Q4 2022.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.